PRMT5 and neoplasm: For example, protein arginine methyltransferase 5 (PRMT5) inhibitor EZP015556 effectively inhibited both methylthioadenosine phosphorylase (MTAP)- and MTAP+ tumor organoids, both of which were hallmarked by high 5'-methylthioadenosine (MTA) levels.